Hoffmann-La Roche.Disclosure The authors have declared no conﬂicts of interest. References 1. Hodi FS, O’Day SJ, McDermott DF et al. Improved survival with ipili- mumab in patients with metastatic melanoma. N Engl J Med 2010; 363(8): 711–723.